1. Home
  2. GPK vs CORT Comparison

GPK vs CORT Comparison

Compare GPK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

N/A

Current Price

$15.48

Market Cap

4.8B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$81.88

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPK
CORT
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
7.6B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
GPK
CORT
Price
$15.48
$81.88
Analyst Decision
Hold
Buy
Analyst Count
8
6
Target Price
$19.86
$130.20
AVG Volume (30 Days)
5.4M
821.3K
Earning Date
02-03-2026
11-04-2025
Dividend Yield
2.86%
N/A
EPS Growth
N/A
N/A
EPS
1.70
0.87
Revenue
$8,609,000,000.00
$741,172,000.00
Revenue This Year
N/A
$23.79
Revenue Next Year
$0.21
$40.97
P/E Ratio
$9.05
$92.87
Revenue Growth
N/A
17.92
52 Week Low
$13.93
$49.00
52 Week High
$29.51
$117.33

Technical Indicators

Market Signals
Indicator
GPK
CORT
Relative Strength Index (RSI) 45.89 51.62
Support Level $15.16 $78.07
Resistance Level $15.59 $89.00
Average True Range (ATR) 0.49 3.40
MACD 0.04 -0.11
Stochastic Oscillator 60.04 39.42

Price Performance

Historical Comparison
GPK
CORT

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: